Literature DB >> 22656271

Clarithromycin enhances dasatinib-induced cell death in chronic myeloid leukemia cells, by inhibition of late stage autophagy.

Lisa Schafranek, Tamara M Leclercq, Deborah L White, Timothy P Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22656271     DOI： 10.3109/10428194.2012.698737

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  12 in total

Review 1.  Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond.

Authors:  Wesam Ahmed; Richard A Van Etten
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

2.  Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia.

Authors:  Na Yuan; Lin Song; Suping Zhang; Weiwei Lin; Yan Cao; Fei Xu; Yixuan Fang; Zhen Wang; Han Zhang; Xin Li; Zhijian Wang; Jinyang Cai; Jian Wang; Yi Zhang; Xinliang Mao; Wenli Zhao; Shaoyan Hu; Suning Chen; Jianrong Wang
Journal:  Haematologica       Date:  2014-12-15       Impact factor: 9.941

Review 3.  Autophagy in chronic myeloid leukaemia: stem cell survival and implication in therapy.

Authors:  Gudmundur V Helgason; Arunima Mukhopadhyay; Maria Karvela; Paolo Salomoni; Bruno Calabretta; Tessa L Holyoake
Journal:  Curr Cancer Drug Targets       Date:  2013-09       Impact factor: 3.428

Review 4.  Targeting chronic myeloid leukemia stem cells.

Authors:  Ross Kinstrie; Mhairi Copland
Journal:  Curr Hematol Malig Rep       Date:  2013-03       Impact factor: 3.952

Review 5.  Autophagy in blood cancers: biological role and therapeutic implications.

Authors:  Alessio Nencioni; Michele Cea; Fabrizio Montecucco; Valter D Longo; Franco Patrone; Angelo M Carella; Tessa L Holyoake; G Vignir Helgason
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

6.  What challenges remain in chronic myeloid leukemia research?

Authors:  Angelo M Carella; Susan Branford; Michael Deininger; Francois X Mahon; Giuseppe Saglio; Anna Eiring; Jamshid Khorashad; Thomas O'Hare; John M Goldman
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

7.  Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells.

Authors:  Shota Moriya; Xiao-Fang Che; Seiichiro Komatsu; Akihisa Abe; Tomohiro Kawaguchi; Akihiko Gotoh; Masato Inazu; Akio Tomoda; Keisuke Miyazawa
Journal:  Int J Oncol       Date:  2013-03-28       Impact factor: 5.650

8.  Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.

Authors:  An Mt Van Nuffel; Vidula Sukhatme; Pan Pantziarka; Lydie Meheus; Vikas P Sukhatme; Gauthier Bouche
Journal:  Ecancermedicalscience       Date:  2015-02-24

Review 9.  Survival or death: disequilibrating the oncogenic and tumor suppressive autophagy in cancer.

Authors:  B Liu; X Wen; Y Cheng
Journal:  Cell Death Dis       Date:  2013-10-31       Impact factor: 8.469

10.  Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels.

Authors:  S Pillozzi; M Masselli; L Gasparoli; M D'Amico; L Polletta; M Veltroni; C Favre; G Basso; A Becchetti; A Arcangeli
Journal:  Blood Cancer J       Date:  2016-05-13       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.